Nano-Oncology: Clinical Application for Cancer Therapy and Future Perspectives

Table 7

Liposomes in clinical trials.

Compound	Name	Status	Indication
Liposomal cisplatin	SPI-77	Phase III	Non-small cell lung cancer
Liposomal interleukin 2	Oncolipin	Phase I	Non-hodgking lymphoma
Liposomal annamycin	L-Annamycin	Phase I	Acute lymphocytic leukemia
Liposomal oxaliplatin	Aroplatin	Phase II	Advanced colorectal cancer
Liposomal lurtotecan	OSI-211	Phase II	Ovarian cancer
Cationic liposomal c-Raf AON	LErafAON	Phase I/II	Various
Cationic liposomal EI A pDNA	PLD-EIA	Phase I/II	Breast, Ovarian
Thermosensitive liposomal doxorubicin	Thermodox	Phase III	Breast, liver